Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Certain Dibenzo derivatives may help treat prostate cancer.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Clascoterone may be an effective topical treatment for hair loss.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

ESR2 gene linked to female-pattern hair loss.

Caribine from traditional Chinese medicine may help treat hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Parsley contains compounds that might be good for treating hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

New compounds were made that are promising for prostate cancer therapy.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Higher levels of the DP2 receptor may lead to hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

No clear link between specific gene and hair loss in Mexican brothers.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Understanding androgen receptors, oxidative stress, and inflammation is key to developing better skin disease treatments.

Early hormones shape sex-specific differences in rat glands.